{
  "ticker": "MAP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967402",
  "id": "02967402",
  "pages": 42,
  "price_sensitive": false,
  "date": "20250708",
  "time": "1604",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lltcwlnmm05s.pdf",
  "summary": "Here's the extracted material information from the ASX announcement, formatted concisely for capital markets decisions:\n\n---\n\n### **Capital Raising Announcement (Microba Life Sciences Ltd)**  \n**Structure & Key Details:**  \n- **Placement**:  \n  - Tranche 1: Issued 67,177,796 shares at $0.09/share (raised $6.046M) on 27 June 2025.  \n  - Tranche 2: Proposed 71,711,093 shares at $0.09/share (to raise $6.454M), subject to shareholder approval.  \n- **Share Purchase Plan (SPP)**:  \n  - Underwritten $2.0M offer at $0.09/share (max 22,222,223 shares).  \n- **Options**:  \n  - 1 free option (exercise price $0.14, 2-year expiry) for every 2 shares issued in Placement/SPP.  \n  - Total Placement Options: 69,444,444 (Tranche 1: 33,588,898; Tranche 2: 35,855,546).  \n  - Total SPP Options: 11,111,111.  \n\n**Use of Proceeds**:  \n- Expand commercialization of MetaXplore/MetaPanel in AU/UK.  \n- Strengthen working capital, clinical evidence, and commercial operations.  \n\n**Key Dates**:  \n- **General Meeting**: 8 August 2025 (to approve Resolutions).  \n- **Issue Date for Tranche 2/SPP Shares & Options**: 13 August 2025 (pending approvals).  \n\n**Related Party Participation**:  \n- Directors Pasquale Rombola (600,000 Tranche 2 shares + 300,000 options) and Ian Frazer (833,333 shares + 416,666 options) require shareholder approval.  \n\n**Sonic Healthcare Option**:  \n- 1 option exercisable into max 46,296,296 shares + 11,574,074 attaching options (exercise price: 90% of 30-day VWAP or $0.09, whichever is higher).  \n\n**Projected Capital Structure (Post-Completion)**:  \n- **Shares**: 608,963,089 (undiluted).  \n- **Options**: 107,405,299 (including Placement, SPP, and Sonic options).  \n- **Fully Diluted Shares**: 774,238,758 (if all options exercised).  \n\n**Voting Exclusions**: Votes from related parties/participants in placements excluded for relevant resolutions.  \n\n--- \n\n**Summary**: Shareholder approval sought for $14.5M capital raising (Placement + SPP) and Sonic Option issuance, with key dates and dilution metrics highlighted. Excludes non-material operational/background details.  \n\nNo material information omitted.",
  "usage": {
    "prompt_tokens": 28918,
    "completion_tokens": 592,
    "total_tokens": 29510,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-08T06:51:18.410100"
}